# Adalimumab-ryvk

NDC: 51759-360
Generic name: adalimumab-ryvk
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20250701

FDA application: BLA761299

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51759-360"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51759-360
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2d19a877-1f5a-4731-800a-dddadc424080